Was the Decreasing Trend in Hospital Mortality from Heart Failure Attributable to Improved Hospital Care? The Oregon Experience, 1991-1995ByHanyu Ni, PhD, MPH,Ray E. Hershberger, MDSeptember 1st 1999
The Changing Healthcare Market and How It Has Influenced the Treatment of Cardiovascular Disease - Part IByEdmund R. Becker, PhD,Douglas C. Morris, MD,Steven D. Culler, PhD,Patrick D. Mauldin, PhD,Leslee J. Shaw, PhD,J. David Talley, MD,WillSeptember 1st 1999
The Changing Healthcare Market: Outlook for the Future of Cardiovascular Disease Treatment - Part IIByEdmund R. Becker, PhD,Douglas C. Morris, MD,Steven D. Culler, PhD,Patrick D. Mauldin, PhD,Leslee J. Shaw, PhD,J. David Talley, MD,WillSeptember 1st 1999
Selective Contracting and Patient Outcomes: A Case Study of Formulary Restrictions for Selective Serotonin Reuptake Inhibitor AntidepressantsByDan A. Streja, MD,Rita L. Hui, PharmD,Elani Streja,Jeffrey S. McCombs, PhDSeptember 1st 1999
Is a Third-Trimester Antibody Screen in Rh+ Women Necessary?ByJeffrey M. Rothenberg, MD,Beata Weirermiller, MD,Kelly Dirig, MD,William W. Hurd, MD,Jeanne Schilder, MD,Alan Golichowski, MD, PhDSeptember 1st 1999
Patient Factors Related to the Odds of Receiving Prevention Services in Veterans Health Administration Medical CentersByDonna J. Rabiner, PhD,Laurence G. Branch, PhD,Robert J. Sullivan, Jr., MD, MPHSeptember 1st 1999
Innovative Healthcare for Chronically Ill Older Persons: Results of a National SurveyByChad Boult, MD, MPH,Robert L. Kane, MD,James T. Pacala, MD, MS,Edward H. Wagner, MD, MPHSeptember 1st 1999
Office-Based Surgery and Cost Avoidance in an Obstetrics and Gynecology Residency ProgramByS. J. Carlan, MD,Michael C. Bartfield, MD,Trudy Graves, RN, MS,Diane Lanford, RN,Michael Pinell, MD, MBA,Sherrie Sitarik, RN, BSSeptember 1st 1999
Rethinking Formulary Strategy: Management and Measurement ConsiderationsByMichael E. Nugent, BASeptember 1st 1999
